Dipyridamole and platelet behavior.
Sandler G·Lancet (London, England)
Abstract not available
Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 361–380 · 2138 ms
Sandler G·Lancet (London, England)
Abstract not available
Igoin-Apfelbaum L, Apfelbaum M·Lancet (London, England)
Abstract not available
Luria S M·American journal of optometry and archives of American Academy of Optometry
Abstract not available
Sunahara S·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Abstract not available
Sasinka M, Plenta I, Kaiserová E, +6 more·Ceskoslovenska pediatrie
Abstract not available
Blennow M, Aurelius G, Olin P·Lakartidningen
Abstract not available
McCauley C R, Weil A T·Science (New York, N.Y.)
Abstract not available
Bonzi G, Reguzzoni G, Rocca F, +1 more·La Clinica terapeutica
Abstract not available
Madsen P E, Grove O, Jensen K B, +2 more·Ugeskrift for laeger
Abstract not available
Mazza G, Petracco S·Minerva urologica
Abstract not available
Clyne M B, Freeling P, Ginsborg S·The Practitioner
Abstract not available
Wright G, Baum J, Cogan F, +1 more·Lancet (London, England)
Abstract not available
Klein D L·Pediatrics
Abstract not available
Farebrother M J, Pearce S J, Turner P, +1 more·British journal of diseases of the chest
A placebo-controlled double-blind clinical trial was conducted to determine whether propranolol helps cigarette smokers to stop smoking; 73 subjects entered the trial but at the end of eight weeks only six had stopped smoking, three in the propranolol and three in the placebo group. There was no evidence of any helpful…
McLaurin J W, Graves T A, Komet H·The Laryngoscope
Abstract not available
Psychopharmacology bulletin
Abstract not available
Cattell W R, Taylor G W·American heart journal
Abstract not available
Seltzer A P·Eye, ear, nose & throat monthly
Abstract not available
McNeil C·Journal of the National Cancer Institute
Abstract not available
Boisjolie C R, Sharkey S W, Cannon C P, +4 more·The American journal of cardiology
Because time to treatment in AMI is a critical factor in long-term outcome, it is important that complex trials designed to improve reperfusion therapy do not delay the time to treatment. Participation in the TIMI 5 trial did not significantly prolong our door-to-needle time. These results indicate that, if done carefu…